Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/2214 : 56GlobeNewswire Inc.A Report on the Topics to be Covered in the Webinar
2024/05/2214 : 51Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 called up before UK inflation data
2024/05/2214 : 45Business WireMADES, a Latecoere Company, recognized by RTX with a Premier Award for performance in 2023TSXV:LATLatin American Minerals Inc
2024/05/2214 : 45Business WireMADES, une entreprise du groupe Latecoere, reconnue par RTX avec un « Premier Award » pour ses performances en 2023TSXV:LATLatin American Minerals Inc
2024/05/2214 : 40PR Newswire (US)COMPUTEX 2024 Preview | Embracing the Era of High-Capacity SSDs
2024/05/2214 : 38CointelegraphPEPE reaches new high amid ETH price jump on renewed ETF approval hopeCOIN:PEPEUSDPepe
2024/05/2214 : 38GlobeNewswire Inc.Novaturas Group earned EUR 34.5 mln. in the first quarter
2024/05/2214 : 33Alliance NewsAlliance NewsGET READY: British Land, Close Brothers, M&S, RS, SSE at 0700 BST
2024/05/2214 : 31Alliance NewsAlliance NewsAlliance News UK - start of day
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentLSE:AALBAalberts
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesLSE:0RADOse Immunotherapeutics Sa
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesTG:6OPOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesLSE:0RADOse Immunotherapeutics Sa
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentTG:AACAAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesTG:6OPOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.Nextensa offers its shareholders an optional dividendEU:NEXTANextensa SA
2024/05/2214 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelLSE:0NUTNextensa
2024/05/2214 : 30GlobeNewswire Inc.Nextensa offers its shareholders an optional dividendLSE:0NUTNextensa
2024/05/2214 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
2024/05/2214 : 30GlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelEU:NEXTANextensa SA
2024/05/2214 : 30GlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
2024/05/2214 : 25GlobeNewswire Inc.Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, BelgiumNYSE:BHPBHP Group Limited

最近閲覧した銘柄